JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a significant increase in earnings for the nine months ended September 30, 2024, with sales reaching CNY 1,647.31 million, up from CNY 1,503.35 million the previous year. Net income rose to CNY 45.08 million, compared to CNY 10.95 million a year ago, resulting in basic and diluted earnings per share from continuing operations of CNY 0.063, up from CNY 0.015.